George L. Sing - Director at Regeneron Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
REGN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

George L. Sing - trading volume in the past year for Regeneron Pharmaceuticals, Inc.

Holdings reported by George L. Sing for Regeneron Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 26.3K $31M $1,178.73 Sep 4, 2024 Direct
Common Stock 1K $1.18M $1,178.73 Sep 4, 2024 by Trust for Son
Common Stock 750 $884K $1,178.73 Sep 4, 2024 by Spouse
Common Stock 400 $471K $1,178.73 Sep 4, 2024 by Spouse/Cust Son
Non-Qualified Stock Option (right to buy) 3.34K May 3, 2024 Direct Common Stock

Transactions reported by George L. Sing for Regeneron Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.